secwatch.observer — SEC 8-K summary
======================================

Issuer:     Imunon, Inc. (IMNN)
CIK:        0000749647
Form:       8-K
Filed at:   2025-07-11T23:59:59+00:00
Accession:  0001641172-25-018797
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 3.03, 5.07, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Imunon shareholders approve increase in authorized shares to 350M and reverse split up to 1:18
--------------------------------------------------------------------------------

- Authorized common shares increased from 112.5M to 350M; amendment effective July 11, 2025.
- Reverse stock split approved at board's discretion with ratio between 1:5 and 1:18; no effective date set.
- Approved issuance of shares underlying warrants from May 2025 securities purchase agreement with investors.
- Amendment to 2018 Stock Incentive Plan approved; shares available for issuance increased.
- Directors elected: Michael H. Tardugno and Dr. Donald P. Braun as Class III directors until 2028 annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/749647/000164117225018797/0001641172-25-018797-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/749647/000164117225018797/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-018797

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer